Tailored optimal dosing of angiotensin‐converting enzyme inhibitors and β‐blockers in infantile dilated cardiomyopathy
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.70266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 18.11.2025. Verfasst von Yuji Maruo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Japan Science and Technology Agency.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
ORCID-Profile: Yuji Maruo, Hirokuni Yamazawa, Atsuhito Takeda
Förderung
- Japan Science and Technology Agency
Zitieren
APA
Maruo, Y., Abe, J., Yamazawa, H., & Takeda, A. (2025). Tailored optimal dosing of angiotensin‐converting enzyme inhibitors and β‐blockers in infantile dilated cardiomyopathy. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70266
Vancouver
Maruo Y, Abe J, Yamazawa H, Takeda A. Tailored optimal dosing of angiotensin‐converting enzyme inhibitors and β‐blockers in infantile dilated cardiomyopathy. Pediatrics International. 2025;67(1). doi:10.1111/ped.70266
BibTeX
@article{Maruo2025,
author = {Maruo, Yuji and Abe, Jiro and Yamazawa, Hirokuni and Takeda, Atsuhito},
title = {Tailored optimal dosing of angiotensin‐converting enzyme inhibitors and β‐blockers in infantile dilated cardiomyopathy},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.70266}
}
EUVIMED